Market Insights Health Pharmacies OTC Products

Analgesics (Pharmacies) - Brazil

Brazil

Revenue in the Analgesics market is projected to reach €1.33bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.52%, resulting in a market volume of €1.74bn by 2029.
In global comparison, most revenue will be generated in China (€4,663.00m in 2024).
In relation to total population figures, per person revenues of €6.09 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Analgesics (Pharmacies) market in Brazil is experiencing significant growth and development.

Customer preferences: In Brazil, customers have shown a strong preference for analgesics purchased from pharmacies. This preference can be attributed to the trust and reliability associated with pharmacies, as well as the convenience of purchasing medication alongside other healthcare products. Additionally, customers in Brazil often seek professional advice from pharmacists when selecting analgesics, further driving the demand for these products in pharmacies.

Trends in the market: One major trend in the Analgesics (Pharmacies) market in Brazil is the increasing demand for over-the-counter (OTC) analgesics. This trend can be attributed to several factors. Firstly, the rising awareness and understanding of self-medication among consumers have led to an increased willingness to purchase OTC analgesics without a prescription. Secondly, OTC analgesics are often more affordable and easily accessible compared to prescription medications, making them a preferred choice for many customers. Lastly, the availability of a wide range of OTC analgesics in pharmacies allows customers to choose products that best suit their needs. Another trend in the market is the growing demand for natural and herbal analgesics. Customers in Brazil are increasingly seeking alternative and natural remedies for pain relief, which has led to a rise in the popularity of natural analgesics. This trend can be attributed to the growing awareness of the potential side effects of conventional analgesics and the desire for more holistic approaches to healthcare. Pharmacies in Brazil have responded to this trend by expanding their range of natural and herbal analgesics to cater to the changing preferences of customers.

Local special circumstances: Brazil has a large population with a significant portion of the population suffering from chronic pain conditions. This has resulted in a high demand for analgesics in the country. Additionally, Brazil has a well-established healthcare system with a strong presence of pharmacies in both urban and rural areas. This widespread accessibility to pharmacies has contributed to the growth of the Analgesics (Pharmacies) market in Brazil.

Underlying macroeconomic factors: The development of the Analgesics (Pharmacies) market in Brazil can also be attributed to several macroeconomic factors. Firstly, the increasing disposable income of the population has allowed more people to afford healthcare products, including analgesics. Additionally, the aging population in Brazil has contributed to the growth of the market, as older individuals are more likely to experience chronic pain conditions and require analgesics. Furthermore, the government's focus on improving healthcare infrastructure and access to medication has also played a role in the development of the market. In conclusion, the Analgesics (Pharmacies) market in Brazil is experiencing growth and development due to customer preferences for pharmacy purchases, trends in the market such as the demand for OTC and natural analgesics, local special circumstances such as the high prevalence of chronic pain conditions, and underlying macroeconomic factors such as increasing disposable income and an aging population.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.